ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $905,057 | -25.9% | 35,423 | -16.8% | 0.00% | 0.0% |
| Q2 2023 | $1,221,251 | +964.5% | 42,582 | +789.7% | 0.00% | – |
| Q1 2023 | $114,720 | +270.6% | 4,786 | +162.2% | 0.00% | – |
| Q4 2022 | $30,952 | +82.1% | 1,825 | +58.4% | 0.00% | – |
| Q3 2022 | $17,000 | -22.7% | 1,152 | +37.5% | 0.00% | – |
| Q1 2022 | $22,000 | -31.2% | 838 | -5.3% | 0.00% | – |
| Q4 2021 | $32,000 | – | 885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |